# Oxymetazoline Versus Sodium Hypochlorite as Hemostatic Agents in MTA Pulpotomy of Primary Molars

> **NCT07675330** · NA · NOT_YET_RECRUITING · sponsor: **Cairo University** · enrollment: 50 (estimated)

## Conditions studied

- Pulp Disease, Dental
- Pulp Therapy in Primary Molars
- Pulpitis - Reversible
- Pulp Inflammation
- Vital Pulp Therapies
- Carious Exposure of Pulp
- Primary Molar Tooth
- Primary Molar Pulpotomy

## Interventions

- **OTHER:** Oxymetazoline 0.05% nasal solution
- **OTHER:** Sodium Hypochlorite Solution

## Key facts

- **NCT ID:** NCT07675330
- **Lead sponsor:** Cairo University
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2026-08
- **Primary completion:** 2026-12
- **Final completion:** 2027-12
- **Target enrollment:** 50 (ESTIMATED)
- **Last updated:** 2026-06-30


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07675330

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07675330, "Oxymetazoline Versus Sodium Hypochlorite as Hemostatic Agents in MTA Pulpotomy of Primary Molars". Retrieved via MORVS 2026-10-20 from https://api.morvs.ai/clinical/NCT07675330. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*